Orchard Therapeutics plc Annual Share-based Payment Arrangement, Expense in USD from 2016 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Orchard Therapeutics plc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2016 to 2022.
  • Orchard Therapeutics plc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was $2.47M, a 28.8% decline year-over-year.
  • Orchard Therapeutics plc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2023 was $12.5M, a 28.3% decline year-over-year.
  • Orchard Therapeutics plc annual Share-based Payment Arrangement, Expense for 2022 was $16M, a 29% decline from 2021.
  • Orchard Therapeutics plc annual Share-based Payment Arrangement, Expense for 2021 was $22.5M, a 19.4% decline from 2020.
  • Orchard Therapeutics plc annual Share-based Payment Arrangement, Expense for 2020 was $28M, a 44% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $16M -$6.53M -29% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-14
2021 $22.5M -$5.43M -19.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 $28M +$8.54M +44% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 $19.4M +$12.7M +187% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-02
2018 $6.77M +$5.75M +564% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
2017 $1.02M +$815K +400% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $204K Jan 1, 2016 Dec 31, 2016 20-F 2019-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.